Evogene (EVGN) News
NASDAQ: EVGNIndustrialsAgricultural ChemicalsUSD
0.3162+0.0032 (+1.02%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
EVGN news summary
We found 3 recent headlines mentioning Evogene (EVGN): 2 in the past week and 3 in the past 30 days, most often from Nasdaq, PR Newswire. For price context, EVGN is up 1.02% at $0.3162. The most recent story, "Evogene (EVGN) Q3 2026 Earnings Call Transcript", was published by Nasdaq on Nov 19, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Evogene headlines
- Evogene (EVGN) Q3 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The MoNasdaq
- Evogene Reports Financial Results for the Third Quarter and First Nine Months of 2026, Highlighting Progress in Two Internal Development ProgramsCompany advances its internally developed drug discovery program targeting acute graft-versus-host disease (aGVHD) and AgPlenus' fungicide discovery programs targeting novel MoA against Septoria…PR Newswire
- Evogene Targets Acute GVHD With AI-Driven Drug Discovery Program(RTTNews) - Evogene Ltd. (EVGN), an AI-enabled company developing small molecules for pharmaceutical and agricultural markets, announced acute graft-versus-host disease as the target indication for…NasdaqEVGN, BRK.A